![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Abbott’s Cardiac Mapping System Cleared in Europe, Australia
Abbott’s Cardiac Mapping System Cleared in Europe, Australia
![abbott-logo.gif](https://www.fdanews.com/ext/resources/test/Drug-Images/abbott-logo.gif?t=1614806228&width=430)
Abbott has received CE mark certification and Australian approval for its EnSite X EP system, a 3D cardiac mapping platform.
The system maps the electrical signals that control cardiac rhythms, enabling physicians to identify electrical disruptions causing heart rhythm problems and to target ablation therapy.
The EnSite X EP system creates a 3D model of the patient’s heart anatomy and uses electromagnetic technology to accurately locate Abbott’s sensor-enabled catheters during treatment.
Upcoming Events
-
21Oct